Closed |
S0115 |
Phase II Melphalan + Auto PBSC Trans. for High Risk MM / Amyloidosis - BMT Study |
1/1/2004 |
10/15/2010 |
95% |
|
Published
|
Closed |
S0116 |
D1/3-MAGE-3 His Protein + SB-AS02B/Selected Stage IV, M1a or M1b |
9/15/2002 |
2/15/2004 |
2% |
|
|
Closed |
S0117 |
Phase II Mylotarg™ for Relapsed AML |
4/1/2003 |
10/15/2005 |
60% |
|
|
Closed |
S0119 |
Gemcitabine/Irinotecan Untreated Extensive SCLC |
1/1/2002 |
2/15/2003 |
100% |
|
Published
|
Closed |
S0120 |
Observational MGUS / Asymptomatic Myeloma and Plasma Proliferative Disorders |
6/1/2002 |
4/1/2011 |
97% |
|
Published
|
Closed |
S0121 |
Local Bladder |
11/15/2002 |
6/1/2005 |
9% |
|
|
Closed |
S0122 |
Cisplat/Etopo/RT followed by Cisplat/Etopo/TriAb & TriGem Vaccines in Limited SCLC |
12/15/2002 |
5/15/2003 |
10% |
|
|
Closed |
S0124 |
Cis/Irinotecan vs. Cis/VP-16 in Extensive SCLC |
11/1/2002 |
3/1/2007 |
99% |
|
Published
|
Closed |
S0125 |
Phase II Elderly AML in First Complete Remission |
4/1/2003 |
6/1/2005 |
10% |
|
|
Closed |
S0126 |
ZD1839/BAC/Previously-Untreated & Previously-Treated; Selected IIIB & IV |
12/1/2001 |
7/1/2003 |
100% |
|
Published
|
Closed |
S0127 |
GASTRIC AND GE JUNCTION |
6/1/2002 |
8/15/2003 |
88% |
|
Published
|
Closed |
S0200 |
OVARIAN |
8/15/2002 |
12/15/2004 |
6% |
|
Published
|
Closed |
S0202 |
GALLBLADDER AND CHOLANGIOCARCINOMA |
9/1/2003 |
4/1/2005 |
100% |
|
Published
|
Closed |
S0204 |
Newly Diagnosed Multiple Myeloma Tandem Transplant |
6/15/2002 |
10/15/2005 |
100% |
|
Published
|
Closed |
S0205 |
PANCREATIC |
1/1/2004 |
4/1/2006 |
100% |
|
Published
|
Closed |
S0207 |
Testicular |
4/1/2002 |
3/1/2005 |
50% |
|
Published
|
Closed |
S0211 |
Ovarian |
4/15/2002 |
1/1/2006 |
77% |
|
Published
|
Closed |
S0213 |
Mantle Cell Lymphoma |
10/1/2002 |
9/1/2006 |
100% |
|
Published
|
Closed |
S0215 |
ADVANCED: Doxetaxel/Vinorelbine/Filgrastim for HER-2 Pos Stage IV Breast Cancer |
9/15/2002 |
1/1/2007 |
84% |
|
Published
|
Closed |
S0216 |
SCCHN |
3/1/2003 |
8/19/2004 |
100% |
|
Published
|